GS0051: Pharmaceutical preparations for the treatment of central nervous system neurological disorders; Parkinson disease, Alzheimer's disease, Schizophrenia, Attention Deficit Hyperactivity Disorder, autism, and age-related memory dysfunction
Case File Event Statements
6/16/2004 - 20 years ago
9 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
8/26/2003 - 21 years ago
8 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
6/3/2003 - 21 years ago
7 - PUBLISHED FOR OPPOSITIONType:PUBO
5/14/2003 - 21 years ago
6 - NOTICE OF PUBLICATIONType:NPUB
3/31/2003 - 21 years ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
3/10/2003 - 21 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
3/5/2003 - 22 years ago
3 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA